About Mybacs
Mybacs is a company based in Baar (Switzerland) founded in 2018 by Adrian Weingart, Sebastian Wahl, and Carl-Philipp von Polheim. Mybacs has raised $5.92 million across 3 funding rounds from investors including naturalX Health Ventures, WENVEST Capital and SevenCommerce & Ventures. Mybacs offers products and services including Dailybacs® Women, Active Debloat, Dietbacs®, Gut & Nutrients Duo, and Weight Balance Duo.
- Headquarter Baar, Switzerland
- Founders Adrian Weingart, Sebastian Wahl, Carl-Philipp von Polheim
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.92 M (USD)
in 3 rounds
-
Latest Funding Round
$5.92 M (USD), Series A
Oct 30, 2023
-
Investors
naturalX Health Ventures
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mybacs
Mybacs offers a comprehensive portfolio of products and services, including Dailybacs® Women, Active Debloat, Dietbacs®, Gut & Nutrients Duo, and Weight Balance Duo.
Supplement for women's gut and overall health support
Aids in reducing bloating and improving digestion
Supports weight management and metabolic health
Combines probiotics with nutrients for enhanced wellness
Targets weight control and gut balance
People of Mybacs
Unlock access to complete
Funding Insights of Mybacs
Mybacs has successfully raised a total of $5.92M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $5.92 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Mybacs
Mybacs has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include naturalX Health Ventures, WENVEST Capital and SevenCommerce & Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A venture capital fund focused on consumer health investments.
|
Locked | Locked | Locked | |
|
Early-stage venture capital is provided by WENVEST Capital.
|
Locked | Locked | Locked | |
|
Venture capital and acceleration offered to media startups.
|
Locked | Locked | Locked |
Investor details for Mybacs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mybacs
Investment portfolio details for Mybacs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Mybacs
Detailed financials for Mybacs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mybacs Comparisons
Peer comparison for Mybacs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Mybacs
Detailed competitors of Mybacs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mybacs
Complete news archive for Mybacs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mybacs
Mybacs was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Mybacs is headquartered in Baar, Switzerland. It is registered at Baar, Zug, Switzerland.
Sebastian Wahl is the current CEO of Mybacs. They have also founded this company.
Mybacs is a funded company, having raised a total of $5.92M across 3 funding rounds to date.
Mybacs was founded in 2018 in Baar, Switzerland, and operates in the health sector. Probiotic supplements are produced and distributed by the company, targeting everyday use or travel needs. Formulations include mixtures of gut bacteria, vitamins, proteins, and minerals. Support is provided for digestion issues, cardiac conditions, and related health concerns through these products.
Mybacs offers Dailybacs® Women, Active Debloat, Dietbacs®, Gut & Nutrients Duo, and Weight Balance Duo.
Mybacs has 6 investors. Key investors include naturalX Health Ventures, WENVEST Capital, SevenCommerce & Ventures, Global Founders Capital, and Joyance Partners.